{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:25Z","timestamp":1786980145035,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00417-019-04411-1","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T08:13:21Z","timestamp":1563264801000},"page":"1971-1979","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical and etiologic characteristics of de novo uveitis in patients aged 60\u00a0years and above: experience of a French tertiary center"],"prefix":"10.1007","volume":"257","author":[{"given":"P.","family":"Grumet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kerever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kodjikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gerfaud-Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De Parisot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jamilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"issue":"12","key":"4411_CR1","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.autrev.2017.10.010","volume":"16","author":"P S\u00e8ve","year":"2017","unstructured":"S\u00e8ve P, Cacoub P, Bodaghi B, Trad S, Sellam J, Bellocq D et al (2017) Uveitis: diagnostic work-up. A literature review and recommendations from an expert committee. Autoimmun Rev 16(12):1254\u20131264","journal-title":"Autoimmun Rev"},{"issue":"3","key":"4411_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","volume":"111","author":"DC Gritz","year":"2004","unstructured":"Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 111(3):491\u2013500 discussion 500","journal-title":"Ophthalmology."},{"issue":"1","key":"4411_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/bjophthalmol-2016-309829","volume":"102","author":"TH Rim","year":"2018","unstructured":"Rim TH, Kim SS, Ham D-I, Yu S-Y, Chung EJ, Lee SC et al (2018) Incidence and prevalence of uveitis in South Korea: a nationwide cohort study. Br J Ophthalmol 102(1):79\u201383","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"4411_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3109\/09273948.2011.580071","volume":"19","author":"M-A Gr\u00e9goire","year":"2011","unstructured":"Gr\u00e9goire M-A, Kodjikian L, Varron L, Grange J-D, Broussolle C, Seve P (2011) Characteristics of uveitis presenting for the first time in the elderly: analysis of 91 patients in a tertiary center. Ocul Immunol Inflamm 19(4):219\u2013226","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"4411_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0161-6420(98)93523-0","volume":"105","author":"K Chatzistefanou","year":"1998","unstructured":"Chatzistefanou K, Markomichelakis NN, Christen W, Soheilian M, Foster CS (1998) Characteristics of uveitis presenting for the first time in the elderly. Ophthalmology. 105(2):347\u2013352","journal-title":"Ophthalmology."},{"issue":"12","key":"4411_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0248-8663(00)00276-9","volume":"21","author":"L Bouillet","year":"2000","unstructured":"Bouillet L, Sarrot Reynauld F, Gonzalvez B, Mouillon M, Romanet JP, Massot C (2000) Uveitis after the age of 60. Rev Med Interne 21(12):1131\u20131132","journal-title":"Rev Med Interne"},{"issue":"7","key":"4411_CR7","first-page":"720","volume":"26","author":"O Kirsch","year":"2003","unstructured":"Kirsch O, Lautier-Frau M, Labetoulle M, Offret H, Frau E (2003) Characteristics of uveitis presenting de novo in the elderly. J Fr Ophtalmol 26(7):720\u2013724","journal-title":"J Fr Ophtalmol"},{"key":"4411_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/eye.1994.59","volume":"8","author":"K Barton","year":"1994","unstructured":"Barton K, Pavesio CE, Towler HM, Lightman S (1994) Uveitis presenting de novo in the elderly. Eye (Lond) 8 ( Pt 3:288\u2013291","journal-title":"Eye (Lond)"},{"issue":"5","key":"4411_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1055\/s-2008-1035548","volume":"204","author":"C Favre","year":"1994","unstructured":"Favre C, Tran VT, Herbort CP (1994) Uveitis in the elderly. Klin Monatsbl Augenheilkd 204(5):319\u2013322","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"10","key":"4411_CR10","first-page":"942","volume":"14","author":"TA Makley","year":"1982","unstructured":"Makley TA, Orlando RG (1982) Uveitis in older patients. Ann Ophthalmol 14(10):942\u2013944","journal-title":"Ann Ophthalmol"},{"issue":"2","key":"4411_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","volume":"103","author":"E Bloch-Michel","year":"1987","unstructured":"Bloch-Michel E, Nussenblatt RB (1987) International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103(2):234\u2013235","journal-title":"Am J Ophthalmol"},{"key":"4411_CR12","doi-asserted-by":"crossref","unstructured":"de Parisot A, Kodjikian L, Errera M-H, Sedira N, Heron E, P\u00e9rard L et al (2017) Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ULISSE). Am J Ophthalmol","DOI":"10.1016\/j.ajo.2017.03.029"},{"issue":"12","key":"4411_CR13","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/S0248-8663(03)00140-1","volume":"24","author":"B Bodaghi","year":"2003","unstructured":"Bodaghi B, Wechsler B, Du-Boutin LTH, Cassoux N, LeHoang P, Piette J-C (2003) Chronic severe uveitis: classification, search for etiology and therapeutic approach. Rev Med Interne 24(12):794\u2013802","journal-title":"Rev Med Interne"},{"issue":"6","key":"4411_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.survophthal.2007.08.015","volume":"52","author":"V Gupta","year":"2007","unstructured":"Gupta V, Gupta A, Rao NA (2007) Intraocular tuberculosis--an update. Surv Ophthalmol 52(6):561\u2013587","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"4411_CR15","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34(10):1218\u20131227","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4411_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777\u2013783","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4411_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25\u201331","journal-title":"Ann Rheum Dis"},{"issue":"8697","key":"4411_CR18","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet. 335(8697):1078\u20131080","journal-title":"Lancet."},{"issue":"5","key":"4411_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L et al (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131(5):647\u2013652","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4411_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ajo.2005.08.025","volume":"141","author":"RD Levinson","year":"2006","unstructured":"Levinson RD, Brezin A, Rothova A, Accorinti M, Holland GN (2006) Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am J Ophthalmol 141(1):185\u2013187","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"4411_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302","journal-title":"Ann Neurol"},{"issue":"6","key":"4411_CR22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/art.20839","volume":"51","author":"S Abad","year":"2004","unstructured":"Abad S, Meyssonier V, Allali J, Gouya H, Giraudet AL, Monnet D et al (2004) Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients. Arthritis Rheum 51(6):974\u2013982","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4411_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/09273940902788221","volume":"17","author":"P Seve","year":"2009","unstructured":"Seve P, Billotey C, Janier M, Grange J-D, Broussolle C, Kodjikian L (2009) Fluorodeoxyglucose positron emission tomography for the diagnosis of sarcoidosis in patients with unexplained chronic uveitis. Ocul Immunol Inflamm 17(3):179\u2013184","journal-title":"Ocul Immunol Inflamm"},{"key":"4411_CR24","doi-asserted-by":"crossref","unstructured":"Acharya NR, Browne EN, Rao N, Mochizuki M, International Ocular Sarcoidosis Working Group. (2018) Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients. Ophthalmology.;125(1):119\u2013126","DOI":"10.1016\/j.ophtha.2017.07.006"},{"key":"4411_CR25","doi-asserted-by":"crossref","unstructured":"Fisson S, Ouakrim H, Touitou V, Baudet S, Ben Abdelwahed R, Donnou S et al (2013) Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis. PLoS One [Internet] 8(2)","DOI":"10.1371\/journal.pone.0052385"},{"issue":"11","key":"4411_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S1726-4901(08)70047-9","volume":"70","author":"Y-M Chung","year":"2007","unstructured":"Chung Y-M, Lin Y-C, Liu Y-T, Chang S-C, Liu H-N, Hsu W-H (2007) Uveitis with biopsy-proven sarcoidosis in Chinese\u2014a study of 60 patients in a uveitis clinic over a period of 20 years. J Chin Med Assoc 70(11):492\u2013496","journal-title":"J Chin Med Assoc"},{"issue":"3\u20134","key":"4411_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF00153496","volume":"72","author":"A Rothova","year":"1989","unstructured":"Rothova A, Alberts C, Glasius E, Kijlstra A, Buitenhuis HJ, Breebaart AC (1989) Risk factors for ocular sarcoidosis. Doc Ophthalmol 72(3\u20134):287\u2013296","journal-title":"Doc Ophthalmol"},{"key":"4411_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/bjo.48.9.461","volume":"48","author":"DG James","year":"1964","unstructured":"James DG, Anderson R, Langley D, Ainslie D (1964) Ocular sarcoidosis. Br J Ophthalmol 48:461\u2013470","journal-title":"Br J Ophthalmol"},{"key":"4411_CR29","unstructured":"Tsen C-L, Chen S-C, Chen Y-S, Sheu S-J (2017) Uveitis as an initial manifestation of acquired immunodeficiency syndrome. Int J STD AIDS:956462417694569"},{"issue":"1","key":"4411_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1869-5760-3-2","volume":"3","author":"S Sudharshan","year":"2013","unstructured":"Sudharshan S, Kaleemunnisha S, Banu AA, Shrikrishna S, George AE, Babu BR et al (2013) Ocular lesions in 1,000 consecutive HIV-positive patients in India: a long-term study. J Ophthalmic Inflamm Infect 3(1):2","journal-title":"J Ophthalmic Inflamm Infect"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04411-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T19:10:44Z","timestamp":1594753844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04411-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["4411"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04411-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"1 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"P. Grumet declares that he has no conflict of interest.S. Kerever declares that he has no conflict of interest.T. Gilbert declares that he has no conflict of interest.L. Kodjikian has received speaker honorarium from ABBVIE, ALLERGAN, BAYER, NOVARTIS, ROCHE, and THEA.M. Gerfaud-Valentin has received a speaker honorarium from SOBI.A. De Parisot declares that she has no conflict of interest.Y. Jamilloux has received a speaker honorarium from SOBI.P. S\u00e8ve has received speaker honorarium from ABBVIE, AKCEA THERAPEUTICS, GSK, NOVARTIS, SOBI, and ROCHE; he is a member of committee PEPITE (NOVARTIS).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}